Efficacy of the Memory Motivation (MEMO) Web Application Training

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

49 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-05-05

Study Completion Date

2019-08-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Memory, attentional, and behavioural symptoms are the clinical hallmarks of Neurocognitive disorders (NCD) such as Alzheimer's disease and related disorders. The World Health Organisation (WHO) guidelines for risk reduction of cognitive decline and dementia indicate that Cognitive training may be offered to older adults with normal cognition and with mild cognitive impairment to reduce the risk of cognitive decline and/or dementia. The use of Information and Communication Technologies (ICT) in the health domain is progressively expanding. The Alzheimer Innovation Association have developed MeMo (Memory Motivation) a free web application that can be used at home by patients.

The objective of the present study was to assess the effectiveness of employing the MeMo platform on cognitive performance in patients suffering from NCD.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Usability of Virtual Reality in Subjects With Mild Cognitive Impairment or Alzheimer's Disease

NCT02176629

MCI Alzheimer's Disease

COMPLETED NA

Validation of a Remediation Method for Memory Disorders Using Motor and Emotional Encoding in Patients With Alzheimer's Disease

NCT06105047

Alzheimer Disease

COMPLETED NA

Validation of a Smartphone Application for the Assessment of Patients With Mild Cognitive Impairment: MemScreen

NCT03811184

Cognitive Impairment Alzheimer Disease

UNKNOWN

Effects of Cognitive Intervention for Older Adults With Memory Decline: A Pilot Study

NCT00609427

Mild Cognitive Impairment

COMPLETED PHASE1

Brain-Computer Interface System for Training Memory and Attention in Elderly

NCT02228187

Alzheimer's Disease Mild Cognitive Impairment Age-Related Cognitive Decline +1 more

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The objective of this study is to evaluate the effectiveness of the MeMo cognitive training exercise platform in patients suffering from neurocognitive disorders. These exercises ,have been developed by the association Innovation Alzheimer and the CoBTeK research team, located with the Nice memory Center at the Institut Claude Pompidou. MeMo can be used freely at home by patients. More specifically, it is a randomized controlled study that aims to compare the evolution of activities cognition and behavior between patients not using these exercises, and patients using these exercises for 12 weeks, 4 sessions per week.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neurocognitive Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

regular use of a web application at home to train cognition and behavior

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Randomization for the allocation of the patient in each group

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MeMo group

MeMo group: experimental: regular use at home of the Memo web application In the Memo group patients were instructed on how to use the application, and allowed to train for 12 weeks. It was also explained that this training needed to be done regularly on a basis of 4 sessions of 30 minutes each per week.

Group Type EXPERIMENTAL

MeMo web application

Intervention Type DEVICE

The patient betwenn 2 consultation could use the application MeMo. MeMo is a web application that can thus be used on any web browser (computer or tablet). On tablet, the application can be installed on home screen to look like a native app, and used offline.

Control group

Regular follow up at the memory center without cognitive training

Group Type PLACEBO_COMPARATOR

Control group

Intervention Type OTHER

the patient have the classical follow up at the memory center (consultation)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MeMo web application

The patient betwenn 2 consultation could use the application MeMo. MeMo is a web application that can thus be used on any web browser (computer or tablet). On tablet, the application can be installed on home screen to look like a native app, and used offline.

Intervention Type DEVICE

Control group

the patient have the classical follow up at the memory center (consultation)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Outpatient consulting the Memory center
* older than 60 years old
* Mini Mental State examination score (MMSE) between 16 and 28 / 30
* met the DSM 5 diagnoses of mild neurocognitive disorders (mild NCD) or major neurocognitive disorders (Major NCD).

Exclusion Criteria

* Patients not able to read and write French
* presence of a hearing or major visual impairment
* a history of premorbid mental retardation
* had already used the MeMo application
* were presently involved in structured memory training activities.

Minimum Eligible Age

60 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No